Literature DB >> 24099995

Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives.

B Vishnu Nayak1, S Ciftci-Yabanoglu, Surender Singh Jadav, Monika Jagrat, Barij N Sinha, G Ucar, Venkatesan Jayaprakash.   

Abstract

Ethyl and phenyl carbamate derivatives of pyrazoline (3a-3h) were synthesized and tested for their MAO inhibitory activity. All the compounds were found to be selective towards MAO-A. Phenyl carbamates (3e-3h) were better than ethyl carbamates (3a-3d) and displayed the best selectivity index. Compound 3f (KiMAO-A; 4.96 ± 0.21 nM) was found to be equally potent as that of standard drug, Moclobemide (KiMAO-A; 5.01 ± 0.13 nM) but with best selectivity index (8.86 × 10(-5)). Molecular docking studies with R &S conformer of 3f revealed S-enantiomer is better than R-enantiomer as reported earlier by other groups. It is proposed that VdW's radii of the substitution (bulkiness) in ring B determine the potency of phenyl carbamates.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Carbamates; Human monoamine oxidase; Inhibitors; MAO; Molecular docking; Pyrazolines; SAR; back-bone; bb; hMAO; human MAO; monoamine oxidase; rMAO; rat MAO; sc; side-chain; structure–activity-relationship

Mesh:

Substances:

Year:  2013        PMID: 24099995     DOI: 10.1016/j.ejmech.2013.09.010

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis.

Authors:  Vishnu Nayak Badavath; İpek Baysal; Gulberk Ucar; Barij Nayan Sinha; Venkatesan Jayaprakash
Journal:  ACS Med Chem Lett       Date:  2015-12-01       Impact factor: 4.345

2.  Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A.

Authors:  Chandrani Nath; Vishnu Nayak Badavath; Abhishek Thakur; Gulberk Ucar; Orlando Acevedo; Mohd Usman Mohd Siddique; Venkatesan Jayaprakash
Journal:  Medchemcomm       Date:  2018-06-08       Impact factor: 3.597

3.  Synthesis, Characterization and Biological Evaluation of New 3,5-Disubstituted-Pyrazoline Derivatives as Potential Anti-Mycobacterium tuberculosis H37Ra Compounds.

Authors:  Kok Tong Wong; Hasnah Osman; Thaigarajan Parumasivam; Unang Supratman; Mohammad Tasyriq Che Omar; Mohamad Nurul Azmi
Journal:  Molecules       Date:  2021-04-05       Impact factor: 4.411

4.  Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach.

Authors:  Aathira Sujathan Nair; Jong-Min Oh; Vishal Payyalot Koyiparambath; Sunil Kumar; Sachithra Thazhathuveedu Sudevan; Opeyemi Soremekun; Mahmoud E Soliman; Ahmed Khames; Mohamed A Abdelgawad; Leena K Pappachen; Bijo Mathew; Hoon Kim
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

5.  Synthesis, preclinical evaluation and antidepressant activity of 5-substituted phenyl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazole-1-carbothioamides.

Authors:  Bijo Mathew; Jerad Suresh; S Anbazhagan
Journal:  EXCLI J       Date:  2014-04-29       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.